NX-2127 is an orally active, potent BTK inhibitor that induces degradation of mutant BTKC481S in cells, as well as inhibits the proliferation of BTKC481S mutant TMD8 cells. In addition, NX-2127 stimulates T cell activation and increases IL-2 production in primary human T cells.
Molekulargewicht:
719.83
Reinheit:
>99.0%
CAS Nummer:
[2416131-46-7]
Formel:
C39H45N9O5
Target-Kategorie:
BTK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
